Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer-Reference-Cited by-同舟云学术

Guidelines for diagnostics and treatment of aromatase inhibitor-induced bone loss in women with breast cancer

Published:2014 Issue:4 Volume:50 Page:197-203
ISSN:1010-660X
Container-title:Medicina
language:en
Short-container-title:Medicina

Author:

Juozaitytė Elona,Aleknavičius Eduardas,Jančiauskienė Rasa,Česas Alvydas,Pipirienė-Želvienė Teresė,Liutkauskienė Sigita,Krasauskienė Aurelija,Vencevičienė Lina

Publisher

MDPI AG

Subject

General Medicine

Reference23 articles.

1. Survival of women with breast cancer in Kaunas Region, Lithuania;Ivanauskienė;Medicina (Kaunas),2012

2. Management of cancer treatment-induced bone loss;Coleman;Rheumatology,2013

3. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group;Reid;Cancer Treat Rev,2008

4. Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group;Gnant;J Clin Oncol,2007

5. Fracture incidence after 3 years of aromatase inhibitor therapy;Bouvard;Ann Oncol,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteoporosis Awareness and Knowledge in Postmenopausal Breast Cancer Survivors;Turkish Journal of Osteoporosis;2024-04-01

2. Is Periodontal Disease a Red Flag for Breast Cancer Among Postmenopausal Female Smokers? An Update of the Last Decade;December 2020;2020-11-17

3. Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review;Health Expectations;2020-08-03

4. The effects of adjuvant endocrine therapy on bone health in women with breast cancer;Journal of Endocrinology;2019-06

5. Bone health in women with breast cancer;Climacteric;2019-03-21